ClinicalTrials.gov
public full text
Public Domain
Immune Response Following COVID-19 Vaccination
Few trials have reported the safety and efficacy of the COVID-19 vaccines. However, these trials were mostly focused on post-vaccination adverse events and short-term antibody detection with none monitoring the presence of immunoglobulin G (IgG) in blood at long-term follow-up after the vaccination. This study aims to evaluate the immune response in post-vaccinated individuals across a follow-up period of one year.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- COVID-19 Vaccination in Rheumatic Disease Patients#804835
- Immunogenicity After COVID-19 Vaccines in Adapted Schedules#1196427
- Understanding COVID-19 Vaccine Immunity in Tissue and Blood#894909
- COVID-19 VaccinE Response in Rheumatology Patients#148583
- Risk Factors Associated with Adverse Events Following COVID-19 Vaccination in Children Aged 5–11 Years: A Real-World Observational Study.#1091204
Record · ID 1321572
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive